In detail, 65% of the carcinomas (70/107) lacked expression of both receptors, 17% (18/107) were double positive for ERα and PR, 17% (18/107) were solely positive for PR, and 1 tumor was only positive for ERα (Figure 4). The gene discussed is ESR1; the disease is carcinoma.